Across TCGA patient cohorts, TACSTD2 protein abundance is significantly associated with the RNA expression of many other genes, with 8,875 significant associations in total. LSCC shows the largest number of these associations.

The most reproducible TACSTD2-associated genes across cancer lineages are TTC9, LIPH, and GRHL3. Each is linked with TACSTD2 in more than 4 cancer types. Because this analysis shows association rather than direction, both TACSTD2-to-partner and partner-to-TACSTD2 results are reported.

Each partner links to its own Q-omics profile.

protein abundance associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TACSTD2→partner) and Y-score (partner→TACSTD2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OV	TTC9 →	+0.888	+0.601	.006	.008	3	5
LUAD	LIPH →	+1.356	+0.530	<.001	<.001	3	5
HNSC	GRHL3 →	+1.470	+0.637	<.001	<.001	3	5
HNSC	LAD1 →	+1.052	+0.559	<.001	<.001	3	5
OV	PSCA →	+1.235	+0.852	.001	<.001	3	5
OV	DENND5B →	-0.609	-0.850	.002	<.001	3	5

Each partner links to its Q-omics profile. Showing the 6 strongest of 8,875 associations by consensus.

Exploration

TACSTD2 survival (RNA) · tumor vs normal (RNA) · all TACSTD2 data types